MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke

July 17, 2023

(From PR Newswire) MedRhythms' evidence-based neurorehabilitation system to improve walking and ambulation in adults with chronic stroke walking deficits, has been listed as a Class II medical device with the U.S. Food and Drug Administration. The system delivers an intervention based on the principle of Rhythmic Auditory Stimulation. MTI played a significant role in the growth and development of the Portland-based company.

Read more here.